Explore 3 Stock Ideas & Industry Insights Download Free Report

Premium

Taysha Gene Therapies Stock Jumps 15% as Canaccord Genuity Raises Price Target to $17 on CNS Gene Therapy Pipeline Momentum

Shares of Taysha Gene Therapies climbed 15 per cent on Wednesday after Canaccord Genuity raised its price target on the stock to $17 from $14, a move that reflects mounting analyst confidence in the Dallas-based company's clinical trajectory and the broadening commercial potential of …

Nitish Kishor | 15 April 2026

SEC Scraps $25,000 Day-Trading Rule: Robinhood and Webull Shares Surge as FINRA Opens Markets to Retail Investors

Shares of Robinhood Markets and Webull rose sharply in premarket trading on Wednesday after the Securities and Exchange Commission approved a plan by the Financial Industry Regulatory Authority to dismantle the Pattern Day Trader rule — a two-decade-old restriction that has long been a …

Nitish Kishor | 15 April 2026

US Sector Performance Analysis: Materials Erupt and Defensives Snap Back in Broad Advance

The US equity market session on April 14, 2026, showcased a broad-based and highly constructive advance, with 9 of the 11 major sectors finishing in positive territory. Rather than a pure "risk-on" or "risk-off" dynamic, institutional capital executed a classic "barbell" strategy—aggressively accumulating high-beta …

Robert Luong | 14 April 2026

US Sector Momentum Analysis: Tech and Real Estate Take the Lead as Financials Falter

The US sector rotation on April 14, 2026, reveals a market undergoing a massive structural realignment. The Relative Rotation Graph (RRG) highlights a changing of the guard at the top of the market. With Information Technology and Real Estate claiming ultimate leadership, and Financials …

Robert Luong | 14 April 2026